Galen Partners is a leading American private investment firm specializing in healthcare-focused growth equity. With nearly $1 billion invested across five funds, the firm has supported the development of over 70 companies. Galen Partners typically engages in Series B, C, and D investment rounds, focusing on scaling companies within the healthcare sector.
Notable portfolio companies include Dakim, iscribe, and More.com, which have collectively raised significant capital under Galen's guidance. The firm's investment philosophy centers on fostering innovation in healthcare through strategic growth equity investments. Galen Partners also offers value-added services to portfolio companies, leveraging their extensive industry expertise and network to drive growth and operational excellence.
Galen Partners - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Portfolio Companies3
Follow-on Investments1
Current Portfolio Count1
Top Investment Stages
Series A1 (25.0%)
Series B1 (25.0%)
Series C1 (25.0%)
Series D1 (25.0%)
Stage Mix
Series A 25%Series B 25%Series C 25%Series D 25%
Concentration shown as share of disclosed investments by stage.
Galen Partners - Classification
- Also Known As
- Galen Partners LLC
- NAICS
- 520000Finance and Insurance
- 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
- 523900Other Financial Investment Activities
- 523990All Other Financial Investment Activities
- 523999Miscellaneous Financial Investment Activities
- SIC
- 6700Holding And Other Investment Offices
- 6790Miscellaneous Investing
- 6799Investors, Not Elsewhere Classified
Show 6 more industry codes
- NAICS
- 525000Funds, Trusts, and Other Financial Vehicles
- 523910Miscellaneous Intermediation
- 523940Portfolio Management and Investment Advice
- SIC
- 6000Depository Institutions
- 6720Investment Offices
- 6722Management Investment Offices, Open-end
